Corbus Pharmaceuticals Holdings, Inc. (CRBP)
3.31
-0.10
(-2.93%)
USD |
NASDAQ |
Nov 13, 10:06
Corbus Pharmaceuticals Holdings Free Cash Flow (Quarterly) : -21.25M for Sept. 30, 2026
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | -21.25M |
| June 30, 2026 | -29.63M |
| March 31, 2026 | -25.58M |
| December 31, 2025 | -15.93M |
| September 30, 2025 | -15.55M |
| June 30, 2025 | -16.60M |
| March 31, 2025 | -16.42M |
| December 31, 2024 | -10.94M |
| September 30, 2024 | -13.94M |
| June 30, 2024 | -8.943M |
| March 31, 2024 | -7.967M |
| December 31, 2023 | -6.009M |
| September 30, 2023 | -7.176M |
| June 30, 2023 | -7.800M |
| March 31, 2023 | -15.12M |
| December 31, 2022 | -7.455M |
| September 30, 2022 | -7.245M |
| June 30, 2022 | -12.23M |
| March 31, 2022 | -10.63M |
| December 31, 2021 | -9.757M |
| September 30, 2021 | 0.857M |
| June 30, 2021 | -17.53M |
| March 31, 2021 | -21.81M |
| December 31, 2020 | -18.17M |
| September 30, 2020 | -27.31M |
| Date | Value |
|---|---|
| June 30, 2020 | -26.62M |
| March 31, 2020 | -28.06M |
| December 31, 2019 | -23.85M |
| September 30, 2019 | -18.28M |
| June 30, 2019 | -16.57M |
| March 31, 2019 | 10.24M |
| December 31, 2018 | -14.31M |
| September 30, 2018 | -8.953M |
| June 30, 2018 | -6.232M |
| March 31, 2018 | -2.869M |
| December 31, 2017 | -9.694M |
| September 30, 2017 | -6.377M |
| June 30, 2017 | -5.756M |
| March 31, 2017 | -6.676M |
| December 31, 2016 | -5.575M |
| September 30, 2016 | -3.121M |
| June 30, 2016 | -2.648M |
| March 31, 2016 | -2.580M |
| December 31, 2015 | -0.974M |
| September 30, 2015 | -2.488M |
| June 30, 2015 | 0.005M |
| March 31, 2015 | -1.282M |
| December 31, 2014 | -1.321M |
| September 30, 2014 | -0.621M |
| June 30, 2014 |
Free Cash Flow Definition
Free Cash Flow is the cash a company has left after paying for its day-to-day operations and investing in its physical assets, such as buildings, equipment and technology. The company can use that cash however it chooses: paying dividends, buying back shares, paying down debt, making acquisitions or keeping it for future growth.
Free Cash Flow (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow (Quarterly) Benchmarks
| Heron Therapeutics, Inc. | -0.896M |
| Tonix Pharmaceuticals Holding Corp. | -39.43M |
| Karyopharm Therapeutics, Inc. | -24.93M |
| Minerva Neurosciences, Inc. | -8.150M |
| Ocugen, Inc. | -15.89M |